TITLE

Pharmacotherapeutic disparities: Racial, ethnic, and sex variations in medication treatment

AUTHOR(S)
Hall-Lipsy, Elizabeth A.; Chisholm-Burns, Marie A.
PUB. DATE
March 2010
SOURCE
American Journal of Health-System Pharmacy;3/15/2010, Vol. 67 Issue 6, p462
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. Variations in the medication treatment received by racial and ethnic minorities and women and the negative health outcomes associated with these differences were examined. Methods. Studies published between January 1990 and June 2008 were identified via electronic searches of MEDLINE, PsychINFO, International Pharmaceutical Abstracts, PubMed, and CINAHL using search terms related to race, ethnicity, sex, drug treatment, and disparity or variation. Articles were excluded if they addressed only medical or surgical care or did not include a statistical analysis of differences in drug treatment based on race, ethnicity, or sex. Data regarding the frequency of reported race, ethnic, and sex differences in medication treatment, the types of treatment differences observed, and associated health outcomes were extracted. Results. A total of 311 research articles were identified that investigated whether race, ethnicity, or sex was associated with disparities in medication treatment. Seventyseven percent (n = 240) of included articles revealed significant disparities in drug treatment across race, ethnicity, and sex (p < 0.05). The most frequent disparity, found in 73% of the articles studied, was differences in the receipt of prescription drugs; however, documented disparities occurred related to differences in the drugs prescribed, drug dosing or administration, and wait time to receipt of a drug. Documented outcomes associated with pharmacotherapeutic disparities included increased rates of hospitalization, decreased rates of therapeutic goal attainment (e.g., lowdensity- lipoprotein cholesterol, blood pressure goals), and decreased rates of survival. Conclusion. A literature review revealed significant disparities in the medication treatment received by racial and ethnic minorities and women.
ACCESSION #
48478507

 

Related Articles

  • Decline in US Breast Cancer Rates After the Women's Health Initiative: Socioeconomic and Racial/Ethnic Differentials. Krieger, Nancy; Chen, Jarvis T.; Waterman, Pamela D. // American Journal of Public Health;Apr2010 Supplement, Vol. 100 Issue S1, pS132 

    Objectives. We investigated whether there were socioeconomic and racial/ ethnic disparities in recent reported declines in overall US breast cancer incidence rates attributed to post-2002 declines in hormone therapy use following publication of the Women's Health Initiative study. Methods. We...

  • Gender Differences in Smoking and Self Reported Indicators of Health. Kirkland, Susan; Greaves, Lorraine; Devichand, Pratima // BMC Women's Health;2004 Supplement 1, Vol. 4, pS7 

    Health Issue: Smoking among Canadian women is a serious public health issue. Using the 1998-99 National Population Health Survey, this study examined underlying factors contributing to differences in prevalence of smoking among subgroups of women and men, and its effects on self-reported...

  • Variations in Health and Health Behaviors by Nativity Among Pregnant Black Women in Philadelphia. Elo, Irma T.; Culhane, Jennifer F. // American Journal of Public Health;Nov2010, Vol. 100 Issue 11, p2185 

    Objectives. We compared health behaviors and health outcomes among US-born, African-born, and Caribbean-born pregnant Black women and examined whether sociodemographic and psychosocial characteristics explained differences among these population subgroups. Methods. We analyzed data from a...

  • When the 'race and gender stuff' seems too hard. Coponi, Gena Dagel // Christian Science Monitor;12/8/97, Vol. 90 Issue 9, p15 

    Opinion. Looks at a conversation between a woman college assistant professor and college student who identifies with Anglo culture about classroom discussions on ethnicity and gender. His plan to go into human resources.

  • Inequalities in maternal health. Pollock, Wendy; King, James F. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p670 

    The authors reflect on inequalities in maternal health that are found between pregnant white women and minority women. They suggest that the routine collection of detailed data on the differences in maternal health that are seen between white and minority women is the key to improving maternal...

  • Gender Differences with Anticoagulation Discontinuation.  // Critical Care Alert;Oct2008 Pharmacology Watch, p1 

    The article discusses gender differences with discontinuation of anticoagulation after unprovoked venous thromboembolism.

  • Gender-specific research underway.  // Total Health;Mar/Apr97, Vol. 19 Issue 1, p12 

    Introduces the Partnership for Women's Health at Columbia University that will focus on a new concept called gender-specific medicine. Who introduced the initiative; Implication of the initiative.

  • Racial and ethnic disparities in Latin America and the Caribbean: a literature review. Giuffrida, Antonio // Diversity in Health & Care;2010, Vol. 7 Issue 2, p115 

    This paper presents a review of the literature on ethnic and racial disparities in health in Latin America and the Caribbean. It begins by describing the concepts of race, ethnicity and indigeneity, and provides demographic estimates of indigenous and Afro-descendant populations in the region....

  • Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. von Wagner, Christian; Baio, Gianluca; Raine, Rosalind; Snowball, Julia; Morris, Stephen; Atkin, Wendy; Obichere, Austin; Handley, Graham; Logan, Richard F; Rainbow, Sandra; Smith, Stephen; Halloran, Stephen; Wardle, Jane // International Journal of Epidemiology;Jun2011, Vol. 40 Issue 3, p712 

    Background An organized, population-based, colorectal cancer screening programme was initiated in England in 2006 offering biennial faecal occult blood testing (FOBT) to adults aged 60–69 years. Organized screening programmes with no associated financial costs to the individual should...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics